Artificial Intelligence in Oncology: Present Potential, Prospective Prospects, And Ethical Reviews

Authors

  • Ammar A. Razzak Mahmood Dept. of Pharmaceutical Chemistry, College of Pharmacy, University of Baghdad. Bab Al-Mouadam,1000, Baghdad,Iraq
  • Dr Roopa Murgod Consultant biochemist, Manipal Hospital, Old Airport Road, Bangalore
  • Saswat swarup Badapanda Drug safety associate-1, Chandigarh University, Mohali
  • Dr. John Abraham Assistant Professor, Department of Family Medicine, St. Johns National Academy of Health Sciences, Bangalore, India- 560034

DOI:

https://doi.org/10.22376/ijtos.2024.2.1.37-45

Keywords:

Artificial Intelligence in Oncology, Oncology, Deep Learning, Colorectal Cancer, Breast Cancer, and Histopathology.

Abstract

Over the last ten years, Artificial Intelligence (AI) has significantly contributed to solving several health issues, such as cancer.Deep Learning (DL), a subset of adaptable AI that facilitates automated identification of important characteristics, is rapidly used in manyfundamental and clinical cancer investigation domains. This review provides a comprehensive overview of recent instances of AI utilizedin oncology. It highlights how DL techniques have effectively resolved previously deemed unsolvable issues and discusses the challengesthat must be addressed for the wider implementation of such applications. In addition, we emphasize valuable resources and datasets thatmight facilitate the use of AI in cancer research. In the next decade, the development of novel AI methods and their practical use willprovide valuable knowledge in the field of cancer. The advancement of AI technology has proven rapid in recent times and is beingincorporated into every facet of life. The medical profession is also advancing in the deployment of AI-equipped medical equipment. AI isanticipated to have a significant impact on achieving the present worldwide movement towards precision medicine. This article offers acomprehensive summary of the historical development of AI and the current advancements in medical AI, with a specific emphasis oncancer.In addition, while AI has significant promise, several unresolved concerns exist.

References

Bajaj A, Vishwakarma DK. A state-of-the-art review on adversarial machine learning in image classification. Multimedia Tools and Applications. 2023 Jun 17:1-66.

Ghazi N, Aarabi MH, Soltanian-Zadeh H. Deep Learning Methods for Identification of White Matter Fiber Tracts: Review of State-of-the-Art and Future Prospective. Neuroinformatics. 2023 Jun 17:1-32.

Bishara D, Xie Y, Liu WK, Li S. A state-of-the-art review on machine learning-based multiscale modeling, simulation, homogenization and design of materials. Archives of computational methods in engineering. 2023 Jan;30(1):191-222.

Pietrzak P, Szczęsny S, Huderek D, Przyborowski Ł. Overview of Spiking Neural Network Learning Approaches and Their Computational Complexities. Sensors. 2023 Mar 11;23(6):3037.

Cooper M, Ji Z, Krishnan RG. Machine learning in computational histopathology: Challenges and opportunities. Genes, Chromosomes and Cancer. 2023.

Han S, Li Y, Gaoa J. Peripheral Blood MicroRNAs as Biomarkers of Schizophrenia: Expectations from A Meta-Analysis That Combines Deep Learning Methods. The World Journal of Biological Psychiatry. 2023 Sep 13(just-accepted):1-46.

Rasool N, Bhat JI. Glioma Brain Tumor Segmentation using Deep Learning: A Review. In2023 10th International Conference on Computing for Sustainable Global Development (INDIACom) 2023 Mar 15 (pp. 484-489). IEEE.

Mcculloch W, Pitts W. A logical calculus of the ideas immanent in nervousactivity. Bull Math Biol. 1990;52:99-115; discussion 173-197.

Shimizu H, Nakayama KI. Artificial intelligence in oncology. Cancer science. 2020 May;111(5):1452-60.

Takahashi Y, Dungubat E, Kusano H, Fukusato T. Artificial intelligence and deep learning: New tools for histopathological diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Computational and Structural Biotechnology Journal. 2023 Mar 30.

Iao WC, Zhang W, Wang X, Wu Y, Lin D, Lin H. Deep Learning Algorithms for Screening and Diagnosis of Systemic Diseases Based on Ophthalmic Manifestations: A Systematic Review. Diagnostics. 2023 Feb 27;13(5):900.

Aromiwura AA, Settle T, Umer M, Joshi J, Shotwell M, Mattumpuram J, Vorla M, Sztukowska M, Contractor S, Amini A, Kalra DK. Artificial intelligence in cardiac computed tomography. Progress in Cardiovascular Diseases. 2023 Sep 7.

Raja SM, Othman SA, Roslan RM. A Short Review on the Imaging Technology in Radiation Therapy. e-Jurnal Penyelidikan dan Inovasi. 2023 Apr 30:108-22.

Rajamani SK, Iyer RS. A Scoping Review of Current Developments in the Field of Machine Learning and Artificial Intelligence. Designing and Developing Innovative Mobile Applications. 2023:138-64.

Wang M, Sushil M, Miao BY, Butte AJ. Bottom-up and top-down paradigms of artificial intelligence research approaches to healthcare data science using growing real-world big data. Journal of the American Medical Informatics Association. 2023 Jul 1;30(7):1323-32.

Knevel R, Liao KP. From real-world electronic health record data to real-world results using artificial intelligence. Annals of the Rheumatic Diseases. 2023 Mar 1;82(3):306-11.

Derevianko A, Pizzoli SF, Pesapane F, Rotili A, Monzani D, Grasso R, Cassano E, Pravettoni G. The Use of Artificial Intelligence (AI) in the Radiology Field: What Is the State of Doctor–Patient Communication in Cancer Diagnosis?. Cancers. 2023 Jan 12;15(2):470.

Nagpal K, Foote D, Liu Y, et al. Development and validation of adeep learning algorithm for improving Gleason scoring of prostatecancer. NPJ Digit Med. 2019;2:48.

Vandenberghe ME, Scott ML, Scorer PW, Soderberg M, BalcerzakD, Barker C. Relevance of deep learning to facilitate the diagnosis ofHER2 status in breast cancer. Sci Rep. 2017;7:45938.

Verghese G, Lennerz JK, Ruta D, Ng W, Thavaraj S, Siziopikou KP, Naidoo T, Rane S, Salgado R, Pinder SE, Grigoriadis A. Computational pathology in cancer diagnosis, prognosis, and prediction–present day and prospects. The Journal of Pathology. 2023 Aug 14.

Pesapane F, De Marco P, Rapino A, Lombardo E, Nicosia L, Tantrige P, Rotili A, Bozzini AC, Penco S, Dominelli V, Trentin C. How radiomics can improve breast cancer diagnosis and treatment. Journal of Clinical Medicine. 2023 Feb 9;12(4):1372.

Hoskinson DC, Dubuc AM, Mason-Suares H. The current state ofclinical interpretation of sequence variants. Curr Opin Genet Dev.2017;42:33-39.

Yin Z, Yao C, Zhang L, Qi S. Application of artificial intelligence in diagnosis and treatment of colorectal cancer: A novel Prospect. Frontiers in Medicine. 2023 Mar 8;10:1128084.

Lee JS, Das A, Jerby-Arnon L, et al. Harnessing synthetic lethality topredict the response to cancer treatment. Nat Commun. 2018;9:2546

Shea A, Bartz J, Zhang L, Dong X. Predicting mutational function using machine learning. Mutation Research/Reviews in Mutation Research. 2023 Mar 23:108457.

National Cancer Institute. Cancer Statistics. Available online: https://www.cancer.gov/about-cancer/understanding/statistics(accessed on 28 January 2022).

DeSantis, C.E.; Ma, J.; Gaudet, M.M.; Newman, L.A.; Miller, K.D.; Goding Sauer, A.; Jemal, A.; Siegel, R.L. Breast cancer statistics,2019. CA Cancer J. Clin. 2019, 69, 438–451

Batchu, S.; Liu, F.; Amireh, A.; Waller, J.; Umair, M. A Review of Applications of Machine Learning in Mammography and FutureChallenges. Oncology 2021, 99, 483–490.

Aboutalib, S.S.; Mohamed, A.A.; Berg, W.A.; Zuley, M.L.; Sumkin, J.H.;Wu, S. Deep learning to distinguish recalled but benignmammography images in breast cancer screening. Clin. Cancer Res. 2018, 24, 5902–5909.

Yala, A.; Schuster, T.; Miles, R.; Barzilay, R.; Lehman, C. A deep learning model to triage screening mammograms: A simulationstudy. Radiology 2019, 293, 38–46.

Rodríguez-Ruiz, A.; Krupinski, E.; Mordang, J.J.; Schilling, K.; Heywang-Köbrunner, S.H.; Sechopoulos, I.; Mann, R.M. Detection of breast cancer with mammography: Effect of an artificial intelligence support system. Radiology 2019, 290, 305–314

Shaukat, A.; Kahi, C.J.; Burke, C.A.; Rabeneck, L.; Sauer, B.G.; Rex, D.K. ACG Clinical Guidelines: Colorectal Cancer Screening2021. Am. J. Gastroenterol. 2021, 116, 458–479

Noor J, Chaudhry A, Batool S. Microfluidic Technology, Artificial Intelligence, and Biosensors As Advanced Technologies in Cancer Screening: A Review Article. Cureus. 2023 May 29;15(5).

Jalayeri Nia G, Arasaradnam RP, Koulaouzidis A. Clinical utility of colon capsule endoscopy: a moving target?. Therapeutic Advances in Gastroenterology. 2023 Oct;16:17562848231195680.

Ramprasad C, Uche-Anya EN, Berzin TM. Artificial Intelligence in Colorectal Cancer Screening. Current Treatment Options in Gastroenterology. 2023 Sep;21(3):272-82.

Ministry of Economy, Trade and Industry. The Medical Device Industry in Japan. Report from the Medical and Assistive Device Industries O_ce, 2018. Available online: https://www.meti.go.jp/committee/kenkyukai/iryou_innovation/pdf/002_05_00.pdf (accessed on 8 February 2018).

Simsek C, Kaan HL, Aihara H. Future Directions for Robotic Endoscopy–Artificial Intelligence (AI), Three-Dimensional (3D) Imaging, and Natural Orifice Transluminal Endoscopic Surgery. Techniques and innovations in gastrointestinal endoscopy. 2023 Jan 1;25(1):95-101.

Du RC, Ouyang YB, Hu Y. Research trends on artificial intelligence and endoscopy in digestive diseases: A bibliometric analysis from 1990 to 2022. World Journal of Gastroenterology. 2023 Jun 14;29(22):3561-73.

Huang J, Fan X, Liu W. Applications and Prospects of Artificial Intelligence-Assisted Endoscopic Ultrasound in Digestive System Diseases. Diagnostics. 2023 Aug 30;13(17):2815.

Nagendra L, Pappachan JM, Fernandez CJ. Artificial intelligence in the diagnosis of thyroid cancer: Recent advances and future directions. Artificial Intelligence in Cancer. 2023 Sep 8;4(1):1-0.

Doeleman T, Hondelink LM, Vermeer MH, van Dijk MR, Schrader AM. Artificial intelligence in digital pathology of cutaneous lymphomas: a review of the current state and future perspectives. InSeminars in Cancer Biology 2023 Jun 17. Academic Press.

Khanagar SB, Alkadi L, Alghilan MA, Kalagi S, Awawdeh M, Bijai LK, Vishwanathaiah S, Aldhebaib A, Singh OG. Application and Performance of Artificial Intelligence (AI) in Oral Cancer Diagnosis and Prediction Using Histopathological Images: A Systematic Review. Biomedicines. 2023 Jun 1;11(6):1612.

Schadendorf, D.; van Akkooi, A.C.J.; Berking, C.; Griewank, K.G.; Gutzmer, R.; Hauschild, A.; Stang, A.; Roesch, A.; Ugurel, S. Melanoma. Lancet 2018, 392, 971–984

Melanoma of the Skin 2019 . In Cancer Stat Facts; National Cancer Institute: Bethesda, MD, USA, 2019. Esteva, A.; Kuprel, B.; Novoa, R.A.; Ko, J.; Swetter, S.M.; Blau, H.M.; Thrun, S. Dermatologist-level classification of skin cancer with deep neural networks. Nature 2017, 542, 115–118

Ma YJ, Moazamian D, Port JD, Edjlali M, Pruvo JP, Hacein-Bey L, Hoggard N, Paley MN, Menon DK, Bonekamp D, Pravatà E. Targeted magnetic resonance imaging (tMRI) of small changes in the T 1 and spatial properties of normal or near normal appearing white and gray matter in disease of the brain using divided subtracted inversion recovery (dSIR) and divided reverse subtracted inversion recovery (drSIR) sequences. Quantitative Imaging in Medicine and Surgery. 2023 Oct 1;13(10):7304337-7337.

Tashima T. Proteolysis-Targeting Chimera (PROTAC) Delivery into the Brain across the Blood-Brain Barrier. Antibodies. 2023 Jun 26;12(3):43.

Ambrosini RD, Wang P, O’Dell WG. Computer-aided detection of metastaticbrain tumors using automated three-dimensional template matching.J Magn Reson Imaging 2010;31(1):85–93.

Jiang P, Li X, Shen H, Chen Y, Wang L, Chen H, Feng J, Liu J. A systematic review of deep learning-based cervical cytology screening: from cell identification to whole slide image analysis. Artificial Intelligence Review. 2023 Oct 5:1-72.

Collins FS, Varmus H. A new initiative on precision medicine. N Engl JMed 2015;372(9):793–795.

Delaney, G., Jacob, S., Featherstone, C. & Barton, M.The role of radiotherapy in cancer treatment:estimating optimal utilization from a review ofevidence- based clinical guidelines. Cancer 104,1129–1137 (2005).

Peters, L. J. et al. Critical impact of radiotherapyprotocol compliance and quality in the treatment ofadvanced head and neck cancer: results from TROG02.02. J. Clin. Oncol. 28, 2996–3001 (2010).

Brade, A. M. et al. Radiation therapy qualityassurance (RTQA) of concurrent chemoradiationtherapy for locally advanced non- small cell lung cancerin the PROCLAIM phase 3 trial. Int. J. Radiat. Oncol.Biol. Phys. 101, 927–934 (2018).

Dinkla, A. M. et al. MR- only brain radiation therapy:dosimetric evaluation of synthetic CTs generated by

a dilated convolutional neural network. Int. J. Radiat.Oncol. Biol. Phys. 102, 801–812 (2018).

Maspero, M. et al. Dose evaluation of fast synthetic-CT generation using a generative adversarial networkfor general pelvis MR- only radiotherapy. Phys. Med.Biol. 63, 185001 (2018).

Men, K. et al. Deep deconvolutional neural networkfor target segmentation of nasopharyngeal cancer inplanning computed tomography images. Front. Oncol.7, 315 (2017).

Mak, R. H. et al. Use of crowd innovation to developan artificial intelligence- based solution for radiationtherapy targeting. JAMA Oncol. 5, 654 (2019).

Jacobs F, D'Amico S, Benvenuti C, Gaudio M, Saltalamacchia G, Miggiano C, De Sanctis R, Della Porta MG, Santoro A, Zambelli A. Opportunities and Challenges of Synthetic Data Generation in Oncology. JCO Clinical Cancer Informatics. 2023 Aug;7:e2300045.

Jain S, Naicker D, Raj R, Patel V, Hu YC, Srinivasan K, Jen CP. Computational Intelligence in Cancer Diagnostics: A Contemporary Review of Smart Phone Apps, Current Problems, and Future Research Potentials. Diagnostics. 2023 Apr 27;13(9):1563.

Hickman, S.E.; Baxter, G.C.; Gilbert, F.J. Adoption of artificial intelligence in breast imaging: Evaluation, ethical constraints andlimitations. Br. J. Cancer 2021, 125, 15–22.

American Society of Clinical Oncology. mCODE: MinimalCommon Oncology Data Elements. https://mcode initi ative.org/.Accessed February 3, 2020.

Howell D, Molloy S, Wilkinson K, et al. Patient-reportedoutcomesin routine cancer clinical practice: a scoping review ofuse, impact on health outcomes, and implementation factors. AnnOncol. 2015;26:1846-1858.

Kundu S. AI in medicine must be explainable. Nat Med. 2021;27:1328.

Navathe AS, Lee VS, Liao JM. How to overcome clinicians’ resistanceto nudges. Harvard Business Review. 2019.

Prasannam RP, Murugan PA, Narayanan RL. Artificial intelligence in dental practice: a review. International Journal of Community Medicine and Public Health. 2023 May;10(5):1955.

Published

05-01-2024

How to Cite

Mahmood, A. A. R., D. R. Murgod, S. swarup Badapanda, and D. J. Abraham. “Artificial Intelligence in Oncology: Present Potential, Prospective Prospects, And Ethical Reviews”. International Journal of Trends in OncoScience, vol. 2, no. 1, Jan. 2024, pp. 37-45, doi:10.22376/ijtos.2024.2.1.37-45.

Issue

Section

Review Articles